Mariner’s Terns Pharmaceuticals TERN Stock Holding History

Mariner’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-557,361	Closed	-$29.4M	–	3896
2026 Q1	$29.4M	Buy	557,361 +15,309	+3%	+$629K	0.03%	375
2025 Q4	$21.9M	Buy	+542,052	New	+$12.5M	0.03%	425

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mariner's TERN Position: Q2 2026 in Review

Mariner sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 557,361 shares — an estimated $29.4M sold.

Mariner first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $29.4M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Mariner reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Mariner sold 557,361 Terns Pharmaceuticals shares in Q2 2026, an estimated $29.4M.
Mariner first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Mariner's Terns Pharmaceuticals position peaked at $29.4M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.